Skip to main content

Want a detailed portfolio tracker?

OverviewPerformanceMetricsFinancialsETFsIndustrySplitsCorrelations
Market CapEPSP/EP/SP/BSharesProfit MarginOperating MarginDebt to EquityRevenueEarningsEBITDAFree Cash FlowTotal DebtTotal AssetsROAROE

Leap Therapeutics (LPTX) Operating Margin (2020 - 2024)

Leap Therapeutics (LPTX) operating margin from Mar 31, 2020 to Dec 31, 2024. The current Leap Therapeutics (LPTX) operating margin is -161200.00%. You can export chart.

Annual Operating Margin

Quarterly Operating Margin

Annual Operating Margin change of Leap Therapeutics (LPTX)

YearOperating MarginChange
2022-14936.84%
+440.80%
2021-2762.00%
+45.16%
2020-1902.67%
-78.39%
2019-8802.63%
N/A

Comparison Leap Therapeutics (LPTX) operating margin with competitors

Leap Therapeutics (LPTX) operating margin is -161200.00%.

TickerNameOperating MarginUpside
VIRVir Biotechnology Inc459241.00%-384.89%
APLMApollomics Inc - Class A431.90%-100.27%
ABUSArbutus Biopharma Corp94.30%-100.06%
SAVACassava Sciences Inc.93.36%-100.06%
RPRXRoyalty Pharma plc - Class A89.29%-100.06%
GLPGGalapagos NV84.24%-100.05%
NEUPNeuphoria Therapeutics Inc79.85%-100.05%
BDTXBlack Diamond Therapeutics Inc77.90%-100.05%
CTNMContineum Therapeutics Inc - Class A77.87%-100.05%
CVACCureVac N.V.74.59%-100.05%
IPSCCentury Therapeutics Inc67.95%-100.04%
FULCFulcrum Therapeutics Inc65.62%-100.04%
AVIRAtea Pharmaceuticals Inc63.06%-100.04%
PLXProtalix BioTherapeutics Inc62.65%-100.04%
PRTAProthena Corporation plc58.80%-100.04%
AUPHAurinia Pharmaceuticals Inc53.31%-100.03%
ADMAAdma Biologics Inc50.90%-100.03%
RPTXRepare Therapeutics Inc50.85%-100.03%
CRMDCorMedix Inc49.96%-100.03%
HCWBHCW Biologics Inc49.78%-100.03%
CPRXCatalyst Pharmaceuticals Inc49.02%-100.03%
SRPTSarepta Therapeutics Inc49.00%-100.03%
HALOHalozyme Therapeutics Inc48.98%-100.03%
KRYSKrystal Biotech Inc46.14%-100.03%
AGENAgenus Inc44.62%-100.03%
CGENCompugen Ltd43.05%-100.03%
SVASinovac Biotech Ltd42.30%-100.03%
EXELExelixis Inc41.15%-100.03%
QTTBQ32 Bio Inc39.80%-100.02%
INVAInnoviva Inc38.94%-100.02%
VRTXVertex Pharmaceuticals Inc38.10%-100.02%
NXTCNextcure Inc36.70%-100.02%
LGNDLigand Pharmaceuticals Inc - Class B33.58%-100.02%
SLNOSoleno Therapeutics Inc33.06%-100.02%
JAZZJazz Pharmaceuticals plc31.49%-100.02%
ARGXArgen X SE30.35%-100.02%
CAICaris Life Sciences Inc - Class A30.19%-100.02%
TNGXTango Therapeutics Inc26.15%-100.02%
GMABGenmab25.11%-100.02%
ZVRAZevra Therapeutics Inc24.40%-100.02%
TECHBio-Techne Corp24.24%-100.02%
INCYIncyte Corp23.66%-100.01%
RIGLRigel Pharmaceuticals20.21%-100.01%
ICCCImmucell Corp19.01%-100.01%
REGNRegeneron Pharmaceuticals Inc17.83%-100.01%
NERVMinerva Neurosciences Inc17.73%-100.01%
HRMYHarmony Biosciences Holdings Inc17.31%-100.01%
TGTXTG Therapeutics Inc16.98%-100.01%
BMRNBiomarin Pharmaceutical Inc16.92%-100.01%
ONCBeiGene Ltd16.51%-100.01%
PTCTPTC Therapeutics Inc16.50%-100.01%
ENVBEnveric Biosciences Inc13.38%-100.01%
VXRTVaxart Inc13.19%-100.01%
VRNAVerona Pharma Plc12.90%-100.01%
ALNYAlnylam Pharmaceuticals Inc12.01%-100.01%
ASNDAscendis Pharma A/S10.06%-100.01%
APLSApellis Pharmaceuticals Inc9.86%-100.01%
FOLDAmicus Therapeutics Inc8.61%-100.01%
CGEMCullinan Oncology Inc7.24%-100.00%
IMCRImmunocore Holdings plc6.82%-100.00%
NAGENiagen Bioscience Inc5.01%-100.00%
NUVBNuvation Bio Inc - Class A4.66%-100.00%
BMEABiomea Fusion Inc2.46%-100.00%
TLXTelix Pharmaceuticals Ltd1.58%-100.00%
HOTHHoth Therapeutics Inc0.17%-100.00%
BBLGBone Biologics Corp0.04%-100.00%